{"nct_id":"NCT01981837","title":"Phase 2 Study to Evaluate ALN-TTRSC (Revusiran) in Patients With Transthyretin (TTR) Cardiac Amyloidosis","status":"COMPLETED","status_verified_date":"2018-03","start_date":"2013-12","start_date_type":null,"primary_completion_date":"2014-10","primary_completion_date_type":"ACTUAL","completion_date":"2015-01","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["ALNY"]}